Hypothyroid: US Docs More Likely to Prescribe T3/T4
“Physicians in North America are more likely to treat hypothyroidism with combination therapy — by adding synthetic liothyronine (LT3) to the standard therapy of synthetic levothyroxine (LT4) replacement — compared with physicians in other countries.
This is despite conflicting guidelines on the practice, with many physicians seeming to make decisions in response to ongoing symptoms or patients’ requests, according to new survey data.”
It was a surprise. We expected there to be similar prescribing trends across countries, or possibly more combination therapy prescribing in Europe.